Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -7.86%28.24B | -13.95%125.54B | -14.67%31.54B | -21.04%30.64B | 7.71%145.9B | 35.66B | -2.96%34.47B | 18.66%36.96B | 22.09%38.81B | 7.92%135.45B |
| Cost of revenue | -7.19%23.24B | -12.30%103.64B | -13.41%26.26B | -18.90%25.04B | 5.27%118.17B | 28.17B | -4.49%28.81B | 14.23%30.32B | 20.22%30.87B | 11.43%112.25B |
| Gross profit | -10.88%5B | -20.99%21.9B | -20.44%5.28B | -29.38%5.61B | 19.51%27.72B | 7.49B | 5.64%5.66B | 44.19%6.64B | 29.96%7.94B | -6.35%23.2B |
| Operating expense | -13.33%3.56B | -16.16%17.02B | -13.39%5.03B | -17.87%4.1B | 5.40%20.3B | 5.03B | 13.66%4.47B | 32.51%5.8B | -4.14%5B | 0.28%19.26B |
| Operating profit | -4.19%1.44B | -34.22%4.88B | -69.38%256M | -48.91%1.5B | 88.50%7.42B | 2.46B | -16.53%1.19B | 271.56%836M | 228.35%2.94B | -29.21%3.94B |
| Net non-operating interest income (expenses) | 117.78%8M | -52.94%40M | 54.05%57M | -662.50%-45M | 504.76%85M | 44M | 73.33%-4M | 716.67%37M | 500.00%8M | -261.54%-21M |
| Non-operating interest income | 950.00%63M | -4.19%206M | 7.25%74M | -81.25%6M | 49.31%215M | --94M | -28.57%20M | 21.05%69M | 6.67%32M | 0.00%144M |
| Non-operating interest expense | 7.84%55M | 27.69%166M | -46.88%17M | 112.50%51M | -21.21%130M | --50M | -44.19%24M | -49.21%32M | -25.00%24M | 25.95%165M |
| Net investment income | 80.82%-42M | -42.74%-511M | 34.72%-126M | -329.41%-219M | -45.53%-358M | -1M | -25.56%-113M | 9.81%-193M | -24.39%-51M | 2.38%-246M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 168.91%869M | -1.26B | -24M | 0 | ||||||
| Income from associates and other participating interests | 43.23%381M | 104.39%2.09B | 267.22%661M | 383.64%266M | -34.98%1.02B | 449M | 10.39%340M | 11.11%180M | -91.04%55M | 18.15%1.58B |
| Special income (charges) | -592.98%-395M | -117.86%-525M | 47.37%-190M | 49.11%-57M | 411.66%2.94B | -109M | 790.39%3.52B | -114.88%-361M | -918.18%-112M | -168.66%-943M |
| Less:Restructuring and mergern&acquisition | 1,486.96%365M | 26.69%432M | 14.47%182M | -41.03%23M | -6.58%341M | --41M | -60.47%102M | --159M | --39M | --365M |
| Less:Other special charges | -11.76%30M | 102.80%93M | -96.04%8M | -53.42%34M | -674.39%-3.32B | --68M | -1,553.57%-3.66B | 20.24%202M | 563.64%73M | 259.01%578M |
| Less:Write off | ---- | --0 | ---- | ---- | --40M | --0 | ---- | ---- | ---- | --0 |
| Other non-operating income (expenses) | 120.00%22M | 127.27%12M | -25.93%-34M | 350.00%10M | -141.51%-44M | -6M | -7M | -80.00%-27M | 20.00%-4M | 163.86%106M |
| Income before tax | -2.89%1.41B | -30.03%6.86B | 32.63%626M | -48.73%1.46B | 122.46%9.81B | 2.81B | 225.33%3.69B | 3,050.00%472M | 95.72%2.84B | -26.87%4.41B |
| Income tax | -46.59%345M | 18.70%2.27B | -86.71%19M | 5.38%646M | 2,136.17%1.91B | 453M | 335.19%705M | 1,688.89%143M | 357.46%613M | -104.75%-94M |
| Net income | 32.01%1.07B | -41.85%4.59B | 84.19%606M | -63.62%809M | 75.28%7.89B | 2.36B | 207.11%2.98B | 4,800.00%329M | 69.00%2.22B | 11.19%4.5B |
| Net income continuous operations | 32.01%1.07B | -41.85%4.59B | 84.50%607M | -63.64%809M | 75.30%7.89B | --2.36B | 207.00%2.98B | 4,800.00%329M | 69.07%2.23B | 11.16%4.5B |
| Noncontrolling interests | 566.67%40M | 122.64%118M | 170.00%27M | -72.73%6M | -32.05%53M | -3M | 4.35%24M | -75.61%10M | 2,100.00%22M | 18.18%78M |
| Net income attributable to the company | 28.05%1.03B | -42.97%4.47B | 81.82%580M | -63.58%802M | 77.21%7.84B | 2.36B | 212.03%2.96B | 751.02%319M | 67.45%2.2B | 11.05%4.42B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 28.05%1.03B | -42.97%4.47B | 81.82%580M | -63.58%802M | 77.21%7.84B | 2.36B | 212.03%2.96B | 751.02%319M | 67.45%2.2B | 11.05%4.42B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 27.90%10.68 | -42.99%46.48 | 81.87%6.02 | -63.57%8.35 | 77.16%81.53 | 24.54 | 211.97%30.76 | 762.00%3.31 | 67.54%22.92 | 11.05%46.02 |
| Diluted earnings per share | 27.90%10.68 | -42.99%46.48 | 81.87%6.02 | -63.57%8.35 | 77.16%81.53 | 24.5337 | 211.97%30.76 | 749.28%3.31 | 67.54%22.92 | 11.05%46.02 |
| Dividend per share | 0 | 18.18%13 | 18.18%6.5 | 0 | 22.22%11 | 5.5 | 0 | 22.22%5.5 | 0 | 28.57%9 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |